The 5th conference covers the whole array of subspecialties in oncology, such as drug clinical trials, mutational signatures, DNA repair, immune response and other master keys to improve patient outcomes. In fact, DNA repair pathway complexes are often located at the interface of multiple processes that are critical to cancer progression, making their explanation of fundamental biological and medical importance, with huge implications for the development of new therapeutic strategies. Interesting lectures and poster sessions along with lively discussions will foster fruitful interactions, collaborations and insights. MNM’s CEO Pawel Zawadzki, PhD, will also participate in the roundtable, sharing his experience.
